Zalifrelimab Uses, Dosage, Side Effects and more
Zalifrelimab is under investigation in clinical trial NCT03894215 (Phase 2 Study of Anti-pd-1 Independently or in Combination With Anti-ctla-4 in Second-line Cervical Cancer).
| Trade Name | Zalifrelimab |
| Generic | Zalifrelimab |
| Zalifrelimab Other Names | Zalifrelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
